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ABSTRACT Early nutritional insults may increase risk of adult lung disease. We aimed to quantify the
impact of severe acute malnutrition (SAM) on spirometric outcomes 7 years post-treatment and explore
predictors of impaired lung function.
Spirometry and pulse oximetry were assessed in 237 Malawian children (median age: 9.3 years) who had
been treated for SAM and compared with sibling and age/sex-matched community controls. Spirometry
results were expressed as z-scores based on Global Lung Function Initiative reference data for the African–
American population.
Forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were low in all groups (mean
FEV1 z-score: −0.47 for cases, −0.48 for siblings, −0.34 for community controls; mean FVC z-score: −0.32,
−0.38, and −0.15 respectively). There were no differences in spirometric or oximetry outcomes between
SAM survivors and controls. Leg length was shorter in SAM survivors but inter-group sitting heights were
similar. HIV positive status or female sex was associated with poorer FEV1, by 0.55 and 0.31 z-scores,
respectively.
SAM in early childhood was not associated with subsequent reduced lung function compared to local
controls. Preservation of sitting height and compromised leg length suggest “thrifty” or “lung-sparing”
growth. Female sex and HIV positive status were identified as potentially high-risk groups.
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Introduction
The Developmental Origins of Health and Disease (DOHaD) theory proposes that environmental
exposures (such as nutritional insults), during critical time “windows” in early life have long-term
implications for adult health, particularly non-communicable diseases (NCDs) [1]. Respiratory illness is no
exception; there is evidence that early nutritional insults, both prenatally and during early infancy, result
in higher risk of chronic obstructive pulmonary disease (COPD) and asthma [2, 3]. The exact mechanisms
behind DOHaD are not currently known, but it is hypothesised that disruption of lung development,
particularly alveologenesis, could lead to chronic lung disease in adulthood, particularly when
compounded by adverse environmental factors [4, 5]. Since the majority of alveologenesis is thought to
occur before the age of 2 years [6], nutritional insults during this period could result in long-term
impairments. In particular, severe acute malnutrition (SAM), which is most prevalent in the first 2 years of
life, might have an important biological link to long-term respiratory disease.
Worldwide, SAM affects more than 19 million children under 5 years [7, 8] and is defined as low
weight-for-height (below −3 z-scores using the World Health Organization (WHO) growth standards) or a
low mid-upper-arm circumference (<115 mm) or presence of oedematous malnutrition (a glossary of
nutrition terms and definitions can be found in the supplementary material) [9]. Although some studies have
considered the effects of chronic undernutrition (also known as stunting) [10, 11] and micronutrients [12, 13]
on lung function, there is very little evidence regarding the long-term effects of SAM on lung function.
Understanding whether SAM during infancy and childhood has lasting effects on lung function could
facilitate development of interventions aiming to curb the growing burden of NCDs in developing
countries and improve survival and long-term outcomes post-SAM. The aim of this study was to quantify
the long-term (7-year) effects of SAM on spirometry outcomes, as well as explore predictors of poor lung
function, including severity of stunting and wasting, presence of oedema at admission, exposure to
household cooking smoke, sex and HIV, in a cohort of Malawian SAM survivors [14, 15].
Materials and methods
Study design
This was a longitudinal cohort study that prospectively followed-up ex-SAM “case children”. We estimated
that we would locate and recruit 300 case children plus one sibling and one community control per case.
This was sufficient for detecting differences in lung function between groups equivalent to 0.5 z-scores
(>90% power, 5% significance), generally thought to be the cut-off for clinical significance [16].
Ethical approval for this study was granted by Malawi College of Medicine Research and Ethics
Committee (COMREC) (reference P02/13/1342) and University College London Research Ethics
Committee (reference 4683/001). Besides lung function, other outcomes were also studied: more complete
details of the cohort, as well as additional methods and results have been described elsewhere [17, 18].
Study setting and subjects
The cohort originally included all patients admitted to the nutrition ward for treatment of SAM at the
Queen Elizabeth Central Hospital, Blantyre, Malawi, from July 12, 2006 to March 9, 2007 (1024 children).
The median age of the children at admission was 21.5 months (interquartile range, 15–32 months). Results
of survival and anthropometry at the baseline study and the 1-year follow-up have been described
previously [14, 15]. 47% (477/1024) of the original cohort were known to be alive 1 year post-discharge;
these children formed the “case group” for this study. The sibling control was that closest in age to the
case child, between the ages of 6 and 15.9 years. Those younger than 6 years were not eligible for
spirometry testing, due to the difficulty in obtaining high-quality spirometry in very young children under
field conditions. The community control was defined as a child living in the same community, of the same
sex, and within 12 months of age as the case child. This community control was randomly selected by
spinning a bottle at the case child’s home to select a random direction, then enquiring door-to-door to
find the first eligible child. Children who had ever been treated for acute malnutrition were excluded from
the control groups. Informed written consent was obtained from the child’s parent or guardian; assent was
required from the children themselves. Possible sources of missing data included cases who could not be
located, those who agreed to participate but did not attend the hospital appointment (more often
community controls) and those who failed to achieve spirometry data of acceptable quality.
Variables
Primary lung function outcomes were forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC)
and the FEV1/FVC ratio expressed as z-scores, based on the Global Lung Function Initiative (GLI)
reference equations for the African–American population, which adjust for standing height, age, sex and
ethnicity [16]. Spirometry testing took place in our study room at the hospital using the Easy on-PC
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spirometer (NDD medical, Zurich, Switzerland), operated by N. Lelijveld or E. Chimwezi, and one of three
trained data collectors. Quality control of acceptable spirometry traces was undertaken weekly by
N. Lelijveld. J. Kirkby, who was blinded to the study groups, checked 40% of results. The criteria for
acceptability and repeatability of the spirometry curves were based on American Thoracic Society/
European Respiratory Society recommendations modified slightly for children [19, 20].
Duplicate measures by independent data collectors were made for height and sitting height to the nearest
0.1 cm (Leicester height stadiometer, HM-250P; Marsden Weighing Group, Rotherham, UK), and weight
to the nearest 0.1 kg (MS4202L; Marsden group, Rotherham, UK), following the WHO method [21].
Weight-for-age (WAZ), height-for-age (HAZ) and body mass index (BMI)-for-age (BAZ) z-scores were
calculated using WHO 2007 growth standards [22]. HIV status was established from results in health
passports; if unknown, an HIV test was offered by a trained counsellor, following Malawi national protocol
(using Determine HIV-1/2 (Abbott Laboratories, Irving, TX, USA) and Uni-Gold HIV (Trinity Biotech
PLC, Bray, Ireland) tests). Puberty was recorded as a binary variable, as reported by the participant or
guardian (onset of menarche in girls, voice change in boys). As birthweight was rarely recorded, mothers
were asked whether their child was “small” or “normal/large” at birth, during the baseline data collection;
this follows a method widely used in Demographic and Health Surveys (DHS) (http://dhsprogram.com/).
Pulse oximetry was used to measure oxygen saturation (SpO2) using the NONIN PalmSAT 2500 device
(Nonin Medical Inc., Plymouth, MN, USA) during the iStep exercise test (incremental step test) developed
by UCL Institute of Child Health [23]. Body composition, including lean mass, was measured using
bioelectrical impedance analysis (BIA) (Quadscan 4000; Bodystat Ltd, Douglas, UK). A questionnaire
detailing contra-indications for spirometry and potential confounding factors, including cold symptoms,
asthma, cooking fuel use, socioeconomic circumstances (SEC) and history of respiratory illness was also
administered. These questions were based on the “American Thoracic Society’s ATS-DLD-78C respiratory
questionnaire”, UCL’s “SLIC” study questionnaire and Malawi DHS [24–26]. History of respiratory illness
was assessed by parental reporting. Exposure to household cooking smoke was defined as those reporting
use of solid fuels for cooking inside the home.
Analysis
Primary analysis was based on all children with technically acceptable (grade A–C) spirometry results.
Those with grade D results (i.e. not repeatable) [19] and those with reported current upper respiratory
(cold) symptoms were also included as they were evenly spread across the sample and made no significant
difference to the final conclusions [27]. Basic demographic data for each study group as well as those cases
lost to follow-up are presented (table 1). Data for the three main spirometric outcomes and exercise test
outcomes were examined by allocation group (figure 1) and statistical differences assessed using simple and
multivariable linear regression models (table 2 and table S1). One model was used for each outcome where
the predictor was coded zero for cases, one for siblings and two for community controls. HIV status, age,
sex, SEC derived from asset scores using DHS questions [26], and puberty were included as a priori
potential confounders. For spirometric outcomes, sitting height as a percentage of standing height and leg
length were also explored as potential confounders in further analysis. The difference in odds of completing
the exercise test between allocation groups was calculated using multivariable logistic regression.
For our secondary analysis, HIV status, SEC, sex, history of pneumonia, history of TB, cooking smoke
exposure and body composition (lean/fat mass) were examined for their association with spirometry
outcomes across the entire sample using linear regression. A sex-stratified analysis on cooking smoke
exposure was also conducted to try to explain significant differences in spirometry found between the sexes.
We also used linear regression to explore predictive factors of poor spirometry outcomes in the case group
only. Namely, differences associated with severity of wasting and stunting at admission, presence of
oedema at admission, HIV status, sex, estimated birth size and age at admission (months) were calculated
after adjusting for HIV, SEC and puberty (table 3). For all analyses, a p-value of <0.05 was considered to
indicate statistical significance.
Results
In all, 398 out of 477 (83%) families were contacted; 32 declined to participate, 46 case children had died,
and 320 case children were investigated. The study included 721 children in total (320 cases, 217 sibling
controls and 184 community controls). Those who attempted spirometry and the final number of
technically acceptable results are described in figure 2. The proportion of acceptable results was similar
across the study groups (85% for cases, 87% for siblings and 92% for community controls). Although the
study aimed to recruit one of each type of control per case, not all cases had an eligible sibling, and some
community controls dropped out of the study prior to the hospital appointment. Exploration of important
demographic and health characteristics for the three study groups and those cases lost to follow-up
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indicated that HIV was a key potential confounder in the case group (table 1). All three groups had mean
height, weight, and BMI z-scores below global reference norms (table 1); however, cases were significantly
more stunted than siblings (adjusted mean (95% CI) height difference: −0.2 (−0.4 to −0.0) z-scores) and
community controls (−0.4 (−0.6 to −0.2) z-scores) (see supplementary material for definition of stunting).
Further details of growth and survival outcomes are published elsewhere [18]. There was no statistically
significant difference in chest circumference, chest depth, or sitting height between cases and controls, but
cases had a significantly shorter leg length than either sibling (adjusted difference −1.43 cm, 95% CI −2.3
to −0.5) or community controls (adjusted difference: −1.97 cm, 95% CI −3.0 to −1.0).
Lung function differences across study groups
Although most subjects had spirometry results within the normal range (i.e. within 0±2 z-scores; figure 1),
mean FEV1 was significantly lower than predicted in all the groups (by up to 0.47 z-scores) [16]. Similarly,
TABLE 1 Demographic characteristics for the three study groups and those lost to follow-up
Basic demographics Cases Sibling controls Community controls Cases lost to follow-up
Subjects n 237 164 131 190
Age (range) years 9.3 (7.6–15.3) 11.5 (4.6–15.6) 9.1 (5.2–15.1) 8 (7–19)
Males 128 (54) 76 (46) 68 (52) 108 (57)
Birth order median (interquartile range) 2 (1–4) 2 (2–3) 2 (1–3) 2 (1–3)
Started puberty 7 (3) 12 (7) 6 (5) NA
SEC (asset quintile)
1 (poorest) 50 (21) 36 (22) 22 (17) NA
5 (richest) 44 (19) 28 (17) 28 (21) NA
HIV
Seropositive 65 (28) 5 (3) 3 (2) 44 (23)
Seronegative 155 (65) 100 (61) 75 (57) 121 (64)
Status unknown 17 (7) 59 (36) 53 (40) 25 (13)
Height-for-age z-score −1.8±1.2 −1.5±1.2 −1.3±1.1 NA
Weight-for-age z-score −1.6±1.0 −1.4±1.0 −1.2±1.0 NA
BMI-for-age z-score −0.8±0.9 −0.8±0.9 −0.7±0.9 NA
Sitting height % 52.2±1.5 51.8±1.7 51.8±1.5 NA
Sitting height cm 65.4±4.3 68.2±7.1 66.0±4.7 NA
Leg length cm 59.9±5.5 63.0±9.6 61.6±6.0 NA
Lean mass index 9.02±1.1 9.20±1.0 9.12±1.0 NA
Reported indoor biofuel use (wood/charcoal) 37 (16) ∼16% 18 (14) NA
Reported indoor tobacco use 31 (13) ∼13% 19 (15) NA
History of TB 11 (5) 1 (0.6) 1 (0.8) 4/173 (2)
History of pneumonia admissions 7 (3) 13 (8) 7 (5) NA
Ever admitted to hospital (except SAM) 47 (20) 43 (26) 38 (29) NA
Results are presented as n (%) or mean±SD, unless otherwise indicated. Height-for-age z-score is based on World Health Organization 2007
growth standards. Lean mass index is calculated from impedance results of bioelectrical impedance analysis and height: a higher value
implies more lean mass. Sitting height %=sitting height/standing height×100. History of tuberculosis (TB), pneumonia and hospital admission
were self-reported. Cases lost to follow-up are those who were admitted with severe acute malnutrition (SAM) in the original cohort but could
not be subsequently located. “∼” for sibling controls indicates that this was not measured but assumed to be the same as for cases with whom
they shared a household. NA: not applicable. SEC: socioeconomic circumstances; BMI: body mass index.
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FIGURE 1 Lung function results for cases, siblings and community controls. Solid line with error bars represent mean±SD. Dashed lines indicate
the limits of normality as per Global Lung Function Initiative (GLI) spirometry reference data for the African–American population (i.e. mean (0)
±1.96 z-scores). There were no statistically significant differences in any of the spirometry outcomes among the three groups. Most results fall
within the normal range; however, mean forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were lower than predicted by the
GLI reference for all three groups.
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albeit slightly smaller than for FEV1, deficits were also observed for FVC. There were however no
significant differences in FEV1, FVC or FEV1/FVC z-scores between cases and either type of control (table
2; figure 1). This remained true when adjusting for sitting height or leg length in the regression model.
Additionally, there were no significant differences in SpO2 either at rest or during the iStep exercise test
between the study groups (table S1), although cases were less likely to complete the exercise test than
controls (log odds of completing the test adjusted for age, sex, HIV status and SEC: −0.27 (−0.8; 0.2)
compared Q2
¶
to siblings; −0.47 (−1.0; 0.0) compared to community controls).
Predictors of lung function in the whole sample
In the entire sample, FEV1 and FVC z-scores were significantly lower for HIV-positive children than
HIV-negative children (0.5 and 0.4 z-scores lower respectively, unadjusted p<0.01 for both) with no
significant difference in the FEV1/FVC z-score (p=0.2). There was no difference in spirometry outcomes
for those with a previous pneumonia admission, whereas in those with a history of TB (n=13; note small
sample size), FEV1 and FVC were lower by mean (95% CI) 0.91 (−1.5 to −0.3) and 1.07 (−1.7 to −0.4)
z-scores, respectively (unadjusted p<0.001 for both).
Although there was no difference in FEV1/FVC, FEV1 and FVC z-scores were both significantly lower in
girls than boys for the sample as a whole (unadjusted difference (95% CI): −0.28 (−0.5 to −0.1) z-scores,
p=0.004, and −0.25 (−0.4 to −0.1) z-scores, p=0.012, respectively). These statistically significant deficits
remained after adjusting for HIV status, SEC and puberty (as well as after adjusting for sitting height
percentage and/or leg length). There was no significant difference in age, wealth or HIV status between the
sexes for the sample as a whole, although boys were slightly but statistically significantly more stunted
than girls (unadjusted difference (95% CI) HAZ: −0.2 (−0.4 to −0.04)).
There were no statistically significant differences in spirometry outcomes for those exposed to tobacco
smoke at home or for those who lived in homes that cooked with biofuel inside (wood/charcoal).
Sex-stratified analysis of the whole sample found no statistically significant difference in FEV1 or FVC
z-scores for males exposed and unexposed to household cooking smoke. However, FEV1 was 0.5 (95% CI
−0.0 to 1.0) z-scores lower (p=0.059) in females exposed to household smoke than in unexposed females
(borderline statistical significance; adjusted for HIV and SEC). There were no significant differences in
FVC or FEV1/FVC z-scores.
Lean mass index as calculated from BIA was positively associated with FEV1 and FVC z-scores (after
adjusting for HIV, SEC, age, sex and puberty: r2=0.26, p<0.0001 for FEV1 z-score; and 0.28, p<0.0001 for
FVC z-score). SAM (i.e. study group) was not included as a potential confounder in this section of
analysis, as it was found to have no significant effect on lung function in this sample.
Predictors of lung function in the case group only
We also explored whether factors which differed between the cases at admission could predict poor
spirometry outcomes at 7 years post-discharge (table 3). There was no significant difference in spirometry
outcomes according to the degree of wasting, degree of stunting, age at admission or presence of oedema
at the time of admission, after adjusting for HIV status, SEC and puberty. Reported birth size (i.e.
mother’s report of her child being “normal or big” versus “small”) also had no association with long-term
spirometry outcomes in the case group.
TABLE 2 Results of simple and multivariable linear regression analysis for spirometry outcomes across the three study groups
Cases (n=201) Mean±SD Sibling (n=143) Community (n=121)
Mean±SD Difference case–sibling Mean (SD) Difference case–community
Unadjusted
(95% CI)
Adjusted
(95% CI)
Unadjusted
(95% CI)
Adjusted
(95% CI)
FEV1 z-score −0.47±1.1 −0.48±1.0 0.02 (−0.2 to 0.2) 0.13 (−0.2 to 0.4) −0.34±1.1 −0.13 (−0.4 to 0.1) −0.02 (−0.3 to 0.2)
FVC z-score −0.32±1.0 −0.38±1.1 0.06 (−0.2 to 0.3) 0.20 (−0.0 to 0.5) −0.15±1.1 −0.17 (−0.4 to 0.1) −0.05 (−0.3 to 0.2)
FEV1/FVC z-score −0.21±0.9 −0.15±0.9 −0.06 (−0.3 to 0.1) −0.10 (−0.3 to 0.1) −0.37±1.0 0.16 (−0.1 to 0.4) 0.15 (−0.1 to 0.4)
Adjusted differences include HIV status, socioeconomic circumstances and puberty. When including sitting height % in the model, all p-values
remain >0.05. FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity.
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Discussion
When comparing the spirometric lung function of Malawian children who had been admitted 7 years
previously with an episode of SAM against “healthy” sibling and community controls, all children (cases and
controls) were found to have significant reductions in spirometry as compared to international reference data.
There were however no significant differences in spirometric lung function or oxygen saturation during an
TABLE 3 Results of linear regression analysis comparing effects of potential predictors of poor long-term spirometric lung
function in severe acute malnutrition survivors (case group only)
Potential predictors Adjusted (95% CI)
difference z-score FEV1
Adjusted (95% CI)
difference z-score FVC
Adjusted(95% CI)
difference z-score FEV1/FVC
Severely stunted at admission (HAZ <−3)
(n=92 versus 105)
0.02 (−0.3 to 0.3) 0.25 (−0.1 to 0.6) −0.17 (−0.5 to 0.1)
Severely underweight at admission
(WAZ ⩽−4) (n=92 versus 106)
−0.07 (−0.4 to 0.2) 0.20 (−0.1 to 0.5) −0.46* (−0.7 to −0.2)
Oedema at admission (n=164 versus 34) 0.05 (−0.4 to 0.5) 0.01 (−0.4 to 0.4) 0.25 (−0.1 to 0.6)
HIV positive versus negative (n=53 versus 133) −0.58* (−0.9 to −0.3) −0.49* (−0.8 to −0.2) −0.23 (−0.5 to 0.0)
Poorest versus richest SEC (n=118 versus 76) −0.27 (−0.06 to 0.0) −0.22 (−0.5 to 0.1) 0.01 (−0.3 to 0.3)
Males versus females (n=108 versus 91) 0.32* (0.0 to 0.6) 0.27 (−0.0 to 0.6) 0.06 (−0.2 to 0.3)
Low versus normal birth size
(n=18 versus 176)
−0.02 (−0.6 to 0.5) −0.04 (−0.6 to 0.5) −0.06 (−0.6 to 0.4)
Original admission age ⩽2 years versus
>2 years (n=106 versus 93)
−0.22 (−0.5 to 0.1) −0.21 (−0.5 to 0.1) −0.02 (−0.3 to 0.3)
*: indicates p<0.05. Results are adjusted for HIV status, socioeconomic circumstances (SEC) and puberty. n=201 for all cases with spirometry
results; n presented for each predictor indicates small numbers of missing data for each variable. FEV1: forced expiratory volume in 1 s;
FVC: forced vital capacity; HAZ: height-for-age z-score; WAZ: weight-for-age z-score.
1024 children
admitted 2006/7
117 not found,
430 died
79 not found
46 died
32 declined to 
participate
24 disabled
2 ill/refused
57 didn’t attend 
hospital
36 failed
477 alive at 1 year 
post-discharge
201 acceptable 
spirometry
237 attempted 
spirometry
143 acceptable 
spirometry
164 attempted 
spirometry
121 acceptable 
spirometry
131 attempted 
spirometry
19 <6 yrs old
7 disabled
15 ill/refused
12 didn’t attend 
hospital
8 disabled
19 ill/refused
26 didn’t 
attend 
hospital
20 failed
1 implausible
320 cases 
recruited
184 community 
recruited
217 siblings 
recruited
FIGURE 2 Recruitment flow diagram for spirometry results. Recruitment of sibling and community control only commenced at the time of 7-year
follow-up; hence, their recruitment history starts after that of cases, who were enrolled at admission.
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exercise test between SAM survivors and controls. In the sample as a whole, being HIV positive, of female sex,
having less lean mass and having a history of TB were associated with lower spirometric z-scores. Although
household smoke was not associated with lung function in the sample as a whole, when stratified by sex, we
found that females exposed to indoor cooking smoke had a lower mean FEV1 z-score than unexposed females.
Deficits in spirometric z-scores compared to the international reference seen in all study groups likely
reflects common environmental factors such as the high background levels of chronic undernutrition and
general morbidity found throughout childhood in this region. A recent community survey in urban
Malawian adults found the prevalence of spirometric restriction was 38.6% using NHANES (National
Health and Nutrition Examination Survey) reference ranges (derived from a healthy Caucasian population
in the USA) and 9.0% using local reference ranges [28]. Spirometric restriction was significantly associated
with low BMI, which supports the theory that common environmental factors such as chronic
undernutrition, combined with high population levels of biofuel exposure and HIV, may be sufficient to
cause lung restriction, regardless of early SAM exposures.
Besides high levels of chronic undernutrition, it is important to consider the complex interaction of lung
function, height, sitting height and leg length, as this could also diminish the effects of SAM in these
results. Because sitting height as a percentage of standing height was on the hypothesised causal pathway
between SAM and spirometry outcomes, our results were not adjusted for this variable. However, sitting
height is an important consideration as spirometry z-scores are based on standing height. Although SAM
survivors had a significantly lower HAZ, they had a similar sitting height as controls, which could have
artificially “improved” their lung function z-scores and hence, potentially masked the long-term effects of
SAM. In an attempt to unravel this, regression models including sitting height percentage and leg length
were run but had virtually no effect on results; p-values remained insignificant for all spirometry outcomes.
Owing to this complication, it is important to emphasise that for their standing height, SAM survivors,
compared to controls, have preserved lung function. Despite results from both animal models and some
human studies in India, which suggest that postnatal malnutrition can cause qualitative changes in lung
function beyond merely an effect on lung size [29–31], emerging evidence suggests that nutritional insults
in childhood and/or consequential stunting results in smaller lungs that are not necessarily associated with
restrictive or obstructive defects [32, 33]. This also seems to be true for our stunted SAM survivors, similar
to results recently observed in a population of undernourished Indian children [32]. Another study
hypothesised that although poor linear growth often does not affect lung function, poor weight gain does,
possibly due to its negative effect on muscle function [34]. Our finding that lean mass was positively
associated with FEV1 and FVC z-scores supports this hypothesis that weight, particularly muscle mass, may
be more important for lung function than linear growth, particularly if weight loss has been substantial.
The finding that lung function in our cohort of SAM survivors appears preserved to the level of control
children is particularly interesting considering recently published findings that survivors of SAM have
multiple adverse long-term outcomes compared with controls, including low weight- and height-for-age,
and weaker hand grip strength [18]. Such observations could be explained at least in part by the thrifty
phenotype hypothesis of HALES and BARKER [35, 36], which emphasises that poor growth is often
associated with selective preservation of vital organs at the expense of other organs and tissues. This may
apply to SAM survivors in whom limb growth was compromised during or after the episode of SAM,
whereas sitting height and lung function appear preserved for the majority of survivors. This pattern of
shorter legs but preserved torso height may allow lung function to be preserved by decreasing the “load”
on the lungs, whose primary function is to keep the organs and tissues (especially the brain) supplied with
oxygen (see load/capacity theory for more detail [37]). While the thrifty phenotype hypothesis emphasised
“brain sparing” [38], the need for preserved lung function in order to support brain energy metabolism is
a novel concept hypothesised by these results. It is possible that SAM survivors in this study have been
successfully “thrifty” in leg growth, thereby preserving an important vital organ: the lungs.
Although these results suggest that lung function is unlikely to be a key area for intervention to curb
post-SAM mortality, they do highlight some potentially “high risk” groups. One particularly susceptible
population appears to be children with HIV. There is emerging evidence of an increased prevalence of
chronic lung disease, including both obstructive and restrictive types, in HIV-positive adults [39, 40].
Despite 85% (62/73) of the HIV-positive children in this cohort reportedly taking antiretroviral therapy,
their lung function was relatively impaired when compared to HIV-positive children. Very few studies
have considered the effect of HIV on lung function in children; there is one recent study in India that also
found significantly lower FEV1 and FVC in children aged 5–12 years with vertically transmitted HIV, the
majority of whom were being administered antiretroviral therapy [41]. Repeat infections, such as TB,
combined with lower WAZ and lower lean mass could all contribute to the reduced lung function in the
HIV-positive group.
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Besides HIV, females in this cohort also had significantly lower FEV1 and FVC z-scores compared with
males. We hypothesised that this could be due to a deviation from the reference values because of delayed
puberty in Malawian girls; however, the sex difference is still seen in young girls (<9 years), so this seems
to be an unlikely explanation. The sex difference could also reflect differences in body composition or
biofuel smoke exposure. Male patients in our cohort had significantly more lean mass than girls (based on
BIA); therefore, differences in body composition may have contributed to the observed sex differences in
spirometry. Although we did not find any overall association between spirometry outcomes and living with
a tobacco smoker or cooking with solid fuel inside homes, differential exposure to cooking smoke between
the sexes could also be a contributory factor, especially since biofuel smoke was associated with spirometry
outcomes when our data were stratified by sex. However, we would have expected pollution exposure to
result in an obstructive pattern rather than the restrictive pattern observed. Interventions such as
low-pollution cook stoves, currently being evaluated in Malawi (www.capstudy.org/), could have particular
benefits for high-risk groups.
Limitations
Possible sources of bias in this study include survivor bias, selection bias with regard to controls, and
observer bias. As 46% of the case group are known to have died since admission, survivor bias could have
diminished the observed effects of SAM as only the “healthiest” with the fewest long-term impacts are likely
to have survived. This survivor bias, as well as high rates of HIV and biomass smoke exposure, means that
results may not be generalisable to all settings. In addition, the control group are not necessarily
representative of the Malawian population as a whole, as they were recruited in the same communities as
survivors of SAM. However, based on mean HAZ and WAZ from Malawi’s 2015 DHS, our community
controls appear similar to the general population (HAZ −1.3 versus −1.5 in DHS; WAZ −1.2 versus −0.8 in
DHS) [42]. Selection bias could have also affected the community control group if those who chose to
participate differed systematically from those who declined. This could not be assessed as data were not
available on those who declined or dropped-out of the study. Lastly, observer bias could have influenced the
results as spirometry is an effort-dependent test, and operators were not blinded to the case/control status
of the participants due to risk of data-entry errors. However, this is in part mitigated by the fact that those
conducting quality control and selection of final spirometry traces for analysis were blinded.
Other limitations of this study include the lack of information on some potential confounders such as the
accurate birth weight data. Birth weight is associated with long-term adverse effects on lung function [2]
and is also associated with a higher risk of SAM in infancy [43]. However, using the mother’s estimate as
to whether the child was “small” or “normal” at birth, we found no association with lung function. Finally,
it is important to note that our results may be affected by the length of follow-up. It could be that small
inter-group differences are not yet clinically apparent. Evidence of “lung sparing” growth could indicate
phenotype adaptation, which might not have apparent adverse consequences until much later in life [44].
Future follow-up in adulthood could address this.
Conclusion
Contrary to our initial hypothesis, we found no significant long-term impact of SAM on lung function in
surviving children. This could be due to “thrifty” or “lung-sparing” growth preserving sitting height and
lung function at the expense of limb length. HIV, despite treatment, was associated with adverse effects on
spirometry outcomes, even at these young ages. Females also had significantly poorer lung function than
males in this cohort: this could reflect differences in body composition or cooking smoke exposure. These
groups could be considered high-risk populations in intervention packages seeking to improve lung
function both in survivors of SAM and in the general population.
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